Evidence map›Paper›PMID 39183978›Full record

ArticleNature cardiovascular research2023

Single Cell Multimodal Analyses Reveal Epigenomic and Transcriptomic Basis for Birth Defects in Maternal Diabetes.

Tomohiro Nishino, Sanjeev S Ranade, Angelo Pelonero, Benjamin J van Soldt, Lin Ye, Michael Alexanian, Frances Koback, Yu Huang, Nandhini Sadagopan, Adrienne Lam and 8 more

Abstract read
In one paragraph

Article in Nature cardiovascular research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genetic and Environmental Contributors To Congenital Heart Disease.Current treatment options in cardiovascular medicine · 2025
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Tomohiro NishinoGladstone Institutes; San Francisco, CA, USA.
Sanjeev S RanadeGladstone Institutes; San Francisco, CA, USA.
Angelo PeloneroGladstone Institutes; San Francisco, CA, USA.
Benjamin J van SoldtGladstone Institutes; San Francisco, CA, USA.
Lin YeGladstone Institutes; San Francisco, CA, USA.
Michael AlexanianGladstone Institutes; San Francisco, CA, USA.
Frances KobackGladstone Institutes; San Francisco, CA, USA.
Yu HuangGladstone Institutes; San Francisco, CA, USA.
Nandhini SadagopanGladstone Institutes; San Francisco, CA, USA.
Adrienne LamGladstone Institutes; San Francisco, CA, USA.
Lyandysha V ZholudevaGladstone Institutes; San Francisco, CA, USA.
Feiya LiGladstone Institutes; San Francisco, CA, USA.
Arun PadmanabhanGladstone Institutes; San Francisco, CA, USA.
Reuben ThomasGladstone Institutes; San Francisco, CA, USA.
Joke G van BemmelGladstone Institutes; San Francisco, CA, USA.
Casey A GiffordGladstone Institutes; San Francisco, CA, USA.
Mauro W CostaGladstone Institutes; San Francisco, CA, USA.
Deepak SrivastavaGladstone Institutes; San Francisco, CA, USA.

Funding

CARDIOGENESIS--MOLECULAR MECHANISMSR01HL057181 · NHLBI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI DEEPAK SRIVASTAVA · 1997 to 2026
$14.0M
Project 3: Control of cardiac transcription by MEF2 and myocardinP01HL146366 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI KROGAN, NEVAN J · 2019 to 2023
$13.7M
Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.R01HL127240 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MCKINSEY, TIMOTHY, SRIVASTAVA, DEEPAK · 2015 to 2022
$6.4M
Aortic Valve Disease: Mechanisms and Therapeutic ApproachesR01HL150100 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI SRIVASTAVA, DEEPAK · 2020 to 2023
$2.7M
Padmanabhan K08 Admin SupplementK08HL157700 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PADMANABHAN, ARUN · 2021 to 2025
$830k
AHRQ HHS R01 HS015100NHLBI NIH HHS K08 HL157700NHLBI NIH HHS P01 HL146366NHLBI NIH HHS R01 HL057181NHLBI NIH HHS R01 HL127240NHLBI NIH HHS R01 HL150100
6 · The paper itself

Abstract

Maternal diabetes mellitus is among the most frequent environmental contributors to congenital birth defects, including heart defects and craniofacial anomalies, yet the cell types affected and mechanisms of disruption are largely unknown. Using multi-modal single cell analyses, here we show that maternal diabetes affects the epigenomic landscape of specific subsets of cardiac and craniofacial progenitors during embryogenesis. A previously unrecognized cardiac progenitor subpopulation expressing the homeodomain-containing protein ALX3 showed prominent chromatin accessibility changes and acquired a more posterior identity. Similarly, a subpopulation of neural crest-derived cells in the second pharyngeal arch, which contributes to craniofacial structures, displayed abnormalities in the epigenetic landscape and axial patterning defects. Chromatin accessibility changes in both populations were associated with increased retinoic acid signaling, known to establish anterior-posterior identity. This work highlights how an environmental insult can have highly selective epigenomic consequences on discrete cell types leading to developmental patterning defects.

Indexed as

Epigenesis, GeneticGene Expression Regulation, DevelopmentalPregnancy in DiabeticsSingle-Cell AnalysisAnimalsCraniofacial AbnormalitiesDisease Models, AnimalEpigenomicsFemaleGene Expression ProfilingHeart Defects, CongenitalHomeodomain ProteinsMiceNeural CrestPregnancySignal TransductionHomeodomain ProteinsTranscription FactorsTretinoin

Identifiers

PMID39183978
PMCPMC11343316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.